The Native Antigen Company is part of LGC Clinical Diagnostics - Learn More

0 Items
Select Page

Download your free eBook: Accelerating Dengue research with the highest quality proteins and antibodies 

The dengue virus poses a significant risk to global health and there is currently no vaccine or specific treatment available for those infected.

A major challenge faced by academic researchers, drug developers and public health scientists is Dengue’s close structural similarity to the Zika virus – which continues to hamper research efforts, requiring more sensitive diagnostic tools to differentiate between them.

In this eBook, we discuss:

    • The challenges to preventing the proliferation of DENV across the globe.
    • The key DENV proteins used in the research and development of vaccines, diagnostics and therapeutics.
    • Overcoming some of the major challenges in DENV research.
    • The advantages of using the highest quality recombinant DENV proteins and antibodies.

Simply fill out the form below to get your copy.

Would you like to be kept informed of the latest news and innovations from the infectious disease community? Please let us know if you would like us to contact you or not by selecting one of the options below.

11 + 15 =